METHOD monitoring planning intracavitary brachytherapy CERVICAL CANCER

摘要

a dosimetric u043fu043bu0430u043du0438u0440u043eu0432u0430u043du0438u00a0 brachytherapy business u0432u043du0443u0442u0440u0438u043fu043eu043bu043eu0441u0442u043du043eu0439 cervical cancer, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, using dosimetric plan with 10 active u043fu043eu0437u0438u0446u0438u00a0 we located in combination on each side of the ring 1 - 3 - 1 in 2.5 mm in u043au043eu043bu044cu043fu043eu0441u0442u0430u0442u0435 ring, with the intervals between groups of 35 mm, and 9 active u043fu043eu0437u0438u0446u0438u00a0u043cu0438, courses we are one in 2.5 mm in u043cu0435u0442u0440u0430u0441u0442u0430u0442u0435,u0448u0430u0433u0430u044eu0449u0435u0433u043e source of iridium - 192 to the size of the step of 2.5 mm, in u0430u043fu043fu043bu0438u043au0430u0442u043eu0440u0435 u043cu0435u0442u0440u0430u043au043eu043bu044cu043fu043eu0441u0442u0430u0442u0435 "ring ring u043au043eu043bu044cu043fu043eu0441u0442u0430u0442u0430 Applicator sets" with a diameter of 30 mm and length of u043cu0435u0442u0440u0430u0441u0442u0430u0442u0430 40 mm, angle design u043cu0435u0442u0440u0430u0441u0442u0430u0442u0430 and rings 60, the u043cu0438u043au0440u043eu0441u0435u043bu0435u043au0442u0440u043eu043d hdr.